14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial

      , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
      The Lancet Respiratory Medicine
      Elsevier BV

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <p class="first" id="d4989948e342">There is no proven specific pharmacological treatment for patients with the acute respiratory distress syndrome (ARDS). The efficacy of corticosteroids in ARDS remains controversial. We aimed to assess the effects of dexamethasone in ARDS, which might change pulmonary and systemic inflammation and result in a decrease in duration of mechanical ventilation and mortality. </p>

          Related collections

          Author and article information

          Journal
          The Lancet Respiratory Medicine
          The Lancet Respiratory Medicine
          Elsevier BV
          22132600
          February 2020
          February 2020
          Article
          10.1016/S2213-2600(19)30417-5
          32043986
          1517aedf-e1a1-47d7-9713-228acdf9383a
          © 2020

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article

          scite_

          Similar content1,816

          Cited by508